Today in healthcare news: JPMorgan ran 10,000 simulations that show why an October coronavirus vaccine is unlikely, 10 healthcare stocks to bet on, according to Morgan Stanley, and why we’ll likely not have enough vaccines for everybody until 2024.
Steve Parsons-WPA Pool/Getty Images
JPMorgan sees a ‘low probability’ for coronavirus vaccine data in October after running 10,000 simulations on how the studies will play out
Morgan Stanley handpicked the 10 best healthcare stocks to buy now as investors brace for a major election and the potential for another coronavirus surge
- Morgan Stanley recommended 10 stocks that they think will perform well as the US faces its next presidential election and as the world recovers from the coronavirus pandemic.
- Analysts recommended six pharmaceutical stocks — despite political rhetoric bashing drug prices.
- Here are the top healthcare picks.
We won’t have enough COVID-19 vaccine for everybody until 2024, warns world’s largest vaccine producer
More stories we’re reading:
See you tomorrow! In the meantime, subscribe to this newsletter here.